The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)

BACKGROUND. With the aging population, hepatocellular carcinoma (HCC) in the elderly represents a significant health burden. We aimed to evaluate and compare the efficacy and tolerability of single-agent sorafenib in treating elderly patients with advanced HCC versus the younger population. METHODS....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wong, Hilda, Tang, Yuen Fong, Yao, Tzy-Jyun, Chiu, Joanne, Leung, Roland, Chan, Pierre, Cheung, Tan To, Chan, Albert C., Pang, Roberta W., Poon, Ronnie, Fan, Sheung-Tat, Yau, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Geriatric Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248771/
https://ncbi.nlm.nih.gov/pubmed/22135121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados